Skip to content

Opening book details…

About this document

Vitamin E (300 MG) in The Treatment of MASH - A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study by em11dgonzaga is a document available to read on EtoBox.

A multi-center, randomized, double-blind, placebo-controlled study demonstrated that daily administration of 300 mg of vitamin E for 96 weeks significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The study found notable reductions in liver stiffness, liver enzymes, and proinflammatory cytokines, although it had limited effects on lipid and glucose profiles. No adverse events were deemed related to the treatment, indicating a promising future for vit

Author
em11dgonzaga
Language
EN